Publications by authors named "E Rissanen"

Background: Clinical guidelines are widely used to support clinical decision making, so they could also provide economic information about medical interventions to promote cost-conscious health care. We developed a new way to integrate economic information into the Finnish Current Care Guidelines.

Methods: Our development team consisted of clinical guideline specialists and health economists.

View Article and Find Full Text PDF

Background: Childhood disruptive behaviour disorder associates with various, also costly problems. Parent training is effective in reducing childhood disruptive behaviour. Only a few studies have evaluated the cost-effectiveness of digital parent training in reducing children's disruptive behaviour.

View Article and Find Full Text PDF
Article Synopsis
  • A report studied how a special imaging test called 18 F-PBR06-PET can help find signs of brain cell problems in people with multiple sclerosis (MS).
  • The study looked at 30 scans from 22 MS patients and compared their results with 8 healthy people to see how effective different treatments were.
  • Results showed MS patients had higher brain activity scores than healthy people, and even though stronger treatments helped reduce this activity, it still wasn't completely normal, linking it to their symptoms and brain changes.
View Article and Find Full Text PDF

Background: There are no evidence-based models to support the implementation of school-based bullying prevention programs. Our primary objective is to examine the impact of tailored support on the implementation of the KiVa antibullying program. Our second objective is to evaluate whether the offered support influences student outcomes (e.

View Article and Find Full Text PDF

Objective: Atrophic changes in cerebral gray matter of patients with PD have been reported extensively. There is evidence suggesting an association between cortical gyrification changes and white matter abnormalities. Adenosine A receptors have been shown to be upregulated in cerebral white matter and on reactive astrocytes in preclinical models of neurodegenerative diseases.

View Article and Find Full Text PDF